Rhumbline Advisers Catabasis Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Shares
4 transactions
About Catabasis Pharmaceuticals, Inc.
- Ticker CATB
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,948,800
- Market Cap $657M